An Easier Road to a Hong Kong Listing for Biotech Companies
By: Vivian Yiu, Janet Xiao Ph.D. and Jie Zhou Ph.D.
In June 2017, the Hong Kong Stock Exchange (“HKEx”) initiated a holistic review of the Hong Kong listing regime to enhance its overall competitiveness against other major global listing venues, in particular to attract companies from emerging and innovative sectors. During this review, the
... ›